Different Anti-Candida Activities of Two Human Lactoferrin-derived Peptides, Lfpep and Kaliocin-1

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2005 Jun 28

PMID 15980323

Citations 16

Authors

Monica Viejo-Diaz

Maria T Andres

Jose F Fierro

Affiliations

Soon will be listed here.

Abstract

The synthetic peptides Lfpep and kaliocin-1 include the sequences from positions 18 to 40 and 153 to 183 of human lactoferrin, respectively. Lfpep is a cationic peptide with bactericidal and giardicidal effects, whereas kaliocin-1 is a novel bactericidal peptide that corresponds to a highly homologous sequence present in the transferrin family of proteins. Both peptides presented fungicidal activity against Candida spp., including fluconazole- and amphotericin B-resistant clinical isolates. Lfpep exhibited higher antifungal activity (8- to 30-fold) and salt resistance than kaliocin-1. The killing activity of Lfpep was mediated by its permeabilizing activity on Candida albicans cells, whereas kaliocin-1 was unable to disrupt the cytoplasmic membrane, as indicated by its inability to allow permeation of propidium iodide and the small amount of K+ released. The amino acid sequence of kaliocin-1 includes the "multidimensional antimicrobial signature" conserved in disulfide-containing antimicrobial peptides and a striking similarity to brevinin-1Sa, an antimicrobial peptide from frog skin secretions, exhibiting a "Rana box"-like sequence. These features may be of interest in the design of new antifungals.

Citing Articles

The Archetypal Gamma-Core Motif of Antimicrobial Cys-Rich Peptides Inhibits H-ATPases in Target Pathogens.

Andres M, Yount N, Acosta-Zaldivar M, Yeaman M, Fierro J Int J Mol Sci. 2024; 25(17).

PMID: 39273619 PMC: 11395145. DOI: 10.3390/ijms25179672.

The Antimicrobial Activity of Human Defensins at Physiological Non-Permeabilizing Concentrations Is Caused by the Inhibition of the Plasma Membrane H-ATPases.

Andres M, Fierro P, Antuna V, Fierro J Int J Mol Sci. 2024; 25(13).

PMID: 39000442 PMC: 11242853. DOI: 10.3390/ijms25137335.

Therapeutic Effect of an Antibody-Derived Peptide in a Model of Systemic Candidiasis.

Ottaviano E, Borghi E, Giovati L, Falleni M, Tosi D, Magliani W Int J Mol Sci. 2021; 22(20).

PMID: 34681564 PMC: 8536055. DOI: 10.3390/ijms222010904.

Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.

Zarzosa-Moreno D, Avalos-Gomez C, Ramirez-Texcalco L, Torres-Lopez E, Ramirez-Mondragon R, Hernandez-Ramirez J Molecules. 2020; 25(24).

PMID: 33302377 PMC: 7762604. DOI: 10.3390/molecules25245763.

Milk Peptides Survive In Vivo Gastrointestinal Digestion and Are Excreted in the Stool of Infants.

Beverly R, Huston R, Markell A, McCulley E, Martin R, Dallas D J Nutr. 2019; 150(4):712-721.

PMID: 31883006 PMC: 7138664. DOI: 10.1093/jn/nxz326.

References

Kuipers M, De Vries H, Eikelboom M, Meijer D, Swart P . Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob Agents Chemother. 1999; 43(11):2635-41. PMC: 89536. DOI: 10.1128/AAC.43.11.2635. View

Koshlukova S, Lloyd T, Araujo M, Edgerton M . Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J Biol Chem. 1999; 274(27):18872-9. DOI: 10.1074/jbc.274.27.18872. View

Aguilera O, Ostolaza H, Quiros L, Fierro J . Permeabilizing action of an antimicrobial lactoferricin-derived peptide on bacterial and artificial membranes. FEBS Lett. 2000; 462(3):273-7. DOI: 10.1016/s0014-5793(99)01545-8. View

Situ H, Bobek L . In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. Antimicrob Agents Chemother. 2000; 44(6):1485-93. PMC: 89901. DOI: 10.1128/AAC.44.6.1485-1493.2000. View

Lupetti A, Paulusma-Annema A, Welling M, Senesi S, van Dissel J, Nibbering P . Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob Agents Chemother. 2000; 44(12):3257-63. PMC: 90189. DOI: 10.1128/AAC.44.12.3257-3263.2000. View

Vant Hof W, Reijnders I, Helmerhorst E, Veerman E, Amerongen A . Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity. Antonie Van Leeuwenhoek. 2001; 78(2):163-9. DOI: 10.1023/a:1026572128004. View

Nibbering P, Ravensbergen E, Welling M, van Berkel L, van Berkel P, Pauwels E . Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect Immun. 2001; 69(3):1469-76. PMC: 98043. DOI: 10.1128/IAI.69.3.1469-1476.2001. View

Rothstein D, Spacciapoli P, Tran L, Xu T, ROBERTS F, Dalla Serra M . Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob Agents Chemother. 2001; 45(5):1367-73. PMC: 90475. DOI: 10.1128/AAC.45.5.1367-1373.2001. View

Klepser M . Antifungal resistance among Candida species. Pharmacotherapy. 2001; 21(8 Pt 2):124S-132S. DOI: 10.1592/phco.21.12.124s.34511. View

10.

Sajjan U, Tran L, Sole N, Rovaldi C, Akiyama A, Friden P . P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients. Antimicrob Agents Chemother. 2001; 45(12):3437-44. PMC: 90850. DOI: 10.1128/AAC.45.12.3437-3444.2001. View

11.

Lupetti A, Danesi R, van t Wout J, van Dissel J, Senesi S, Nibbering P . Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. Expert Opin Investig Drugs. 2002; 11(2):309-18. DOI: 10.1517/13543784.11.2.309. View

12.

Steinstraesser L, Tack B, Waring A, Hong T, Boo L, Fan M . Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob Agents Chemother. 2002; 46(6):1837-44. PMC: 127209. DOI: 10.1128/AAC.46.6.1837-1844.2002. View

13.

Yeaman M, Yount N . Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev. 2003; 55(1):27-55. DOI: 10.1124/pr.55.1.2. View

14.

Viejo-Diaz M, Andres M, Perez-Gil J, Sanchez M, Fierro J . Potassium efflux induced by a new lactoferrin-derived peptide mimicking the effect of native human lactoferrin on the bacterial cytoplasmic membrane. Biochemistry (Mosc). 2003; 68(2):217-27. DOI: 10.1023/a:1022657630698. View

15.

Conlon J, Sonnevend A, Patel M, Davidson C, Nielsen P, Pal T . Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii. J Pept Res. 2003; 62(5):207-13. DOI: 10.1034/j.1399-3011.2003.00090.x. View

16.

Farnaud S, Evans R . Lactoferrin--a multifunctional protein with antimicrobial properties. Mol Immunol. 2003; 40(7):395-405. DOI: 10.1016/s0161-5890(03)00152-4. View

17.

Devine D . Antimicrobial peptides in defence of the oral and respiratory tracts. Mol Immunol. 2003; 40(7):431-43. DOI: 10.1016/s0161-5890(03)00162-7. View

18.

Hobson R . The global epidemiology of invasive Candida infections--is the tide turning?. J Hosp Infect. 2003; 55(3):159-68. DOI: 10.1016/j.jhin.2003.08.012. View

19.

Viejo-Diaz M, Andres M, Fierro J . Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity. Antimicrob Agents Chemother. 2004; 48(4):1242-8. PMC: 375254. DOI: 10.1128/AAC.48.4.1242-1248.2004. View

20.

Yount N, Yeaman M . Multidimensional signatures in antimicrobial peptides. Proc Natl Acad Sci U S A. 2004; 101(19):7363-8. PMC: 409924. DOI: 10.1073/pnas.0401567101. View